Profund Advisors LLC reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 23.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,116 shares of the biopharmaceutical company’s stock after selling 7,028 shares during the quarter. Profund […]
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price objective lowered by Royal Bank of Canada from $43.00 to $42.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the biopharmaceutical company’s stock. AGIO has been the subject of a number of other reports. The Goldman […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […]
Agios Pharmaceuticals (NASDAQ:AGIO) Research Coverage Started at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Down 4 3% After Insider Selling themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.